Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Thoracic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Mol Oncol. 2020 Sep;14(9):2332-2351. doi: 10.1002/1878-0261.12683. Epub 2020 Jun 18.
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors around the world. Numerous studies have revealed the function of long noncoding RNAs (lncRNAs) in cancers, including ESCC. In this study, lncRNA small nucleolar RNA host gene 12 (SNHG12), mainly distributed in ESCC cell cytoplasm, was overexpressed in ESCC specimens and CD133 cells. In CD133 ESCC cells, SNHG12 overexpression promoted cell proliferation, migration, epithelial-mesenchymal transition (EMT), and stemness and SNHG12 silencing led to opposite results. Furthermore, SNHG12 sequestered miR-6835-3p and induced the proto-oncogene, polycomb ring finger (BMI1). SNHG12 also enhanced the stability of CTNNB1, the mRNA encoding β-catenin, via recruiting insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) in ESCC. Rescue assays indicated that CTNNB1 and BMI1 were targets for SNHG12 to regulate ESCC cell proliferation, migration, EMT, and stemness. Furthermore, SOX4 (sex-determining region Y-box 4) bound with the SNHG12 promoter to transcriptionally activate SNHG12 in ESCC. Finally, in vivo data showed SNHG12 knockdown retarded tumorigenesis and metastasis in ESCC. In summary, SNHG12 induces proliferation, migration, EMT, and stemness of ESCC cells via post-transcriptional regulation of BMI1 and CTNNB1, indicating that targeting SNHG12 might be a novel target for ESCC treatment.
食管鳞状细胞癌 (ESCC) 是世界上最常见的恶性肿瘤之一。大量研究揭示了长链非编码 RNA (lncRNA) 在癌症中的作用,包括 ESCC。在本研究中,lncRNA 小核仁 RNA 宿主基因 12 (SNHG12) 主要分布在 ESCC 细胞细胞质中,在 ESCC 标本和 CD133 细胞中过度表达。在 CD133 ESCC 细胞中,SNHG12 过表达促进细胞增殖、迁移、上皮-间充质转化 (EMT) 和干性,而 SNHG12 沉默则导致相反的结果。此外,SNHG12 隔离了 miR-6835-3p,并诱导原癌基因多梳抑制因子环指蛋白 1 (BMI1)。SNHG12 还通过招募胰岛素样生长因子 2 mRNA 结合蛋白 2 (IGF2BP2) 增强 ESCC 中编码 β-连环蛋白的 CTNNB1 mRNA 的稳定性。挽救实验表明,CTNNB1 和 BMI1 是 SNHG12 调节 ESCC 细胞增殖、迁移、EMT 和干性的靶标。此外,SOX4(性别决定区 Y 框 4)与 SNHG12 启动子结合,转录激活 ESCC 中的 SNHG12。最后,体内数据表明,SNHG12 敲低可延缓 ESCC 的肿瘤发生和转移。总之,SNHG12 通过转录后调节 BMI1 和 CTNNB1 诱导 ESCC 细胞的增殖、迁移、EMT 和干性,表明靶向 SNHG12 可能是 ESCC 治疗的新靶点。